TH
MEDP icon

TCTC Holdings’s Medpace MEDP Stock Holding History

TCTC Holdings’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-25
Closed -$8.31K – 723
2024
Q4 		$8.31K Buy
+25
New +$8.48K ﹤0.01% 551

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

TCTC Holdings's MEDP Position: Q1 2025 in Review

TCTC Holdings sold out of Medpace (MEDP) in Q1 2025, closing a stake of 25 shares — an estimated $8.31K sold.

TCTC Holdings first reported a position in MEDP in Q4 2024 and held it in 1 quarter. The position peaked at $8.31K in Q4 2024. 586 funds tracked by Wall St. Rank hold MEDP as of Q1 2025.

  • TCTC Holdings reported no remaining Medpace position as of Q1 2025 after selling out during the quarter.
  • TCTC Holdings sold 25 Medpace shares in Q1 2025, an estimated $8.31K.
  • TCTC Holdings first reported a position in Medpace in Q4 2024 and held it in 1 quarter.
  • TCTC Holdings's Medpace position peaked at $8.31K in Q4 2024.
  • 586 funds tracked by Wall St. Rank held Medpace as of Q1 2025.

Based on TCTC Holdings's 13F filing for Q1 2025, filed 7 May 2025.